wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48104335-309CE381-5B94-47E6-B130-FFFF22214E61
Q48104335-309CE381-5B94-47E6-B130-FFFF22214E61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48104335-309CE381-5B94-47E6-B130-FFFF22214E61
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer.
P2860
Q48104335-309CE381-5B94-47E6-B130-FFFF22214E61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48104335-309CE381-5B94-47E6-B130-FFFF22214E61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c8ab50e7021a6836d04d44a369dd0e1b342b2082
P2860
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.